Delivery Order SPE2DB24D2109-SPE2DB25FHXYD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,040.59 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count packages) on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is a neurological medication used as an adjunctive treatment for epilepsy and seizure...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count units) valued at $2,094.26 on September 23, 2025, with completion scheduled for September 24, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed through AmerisourceBergen's existing contract vehicle with DLA. FYCOMPA (perampanel) is an oral antiepileptic medication used as adjunctive therapy for partial-onset seizures and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,049.88 to AmerisourceBergen Drug Corp for FYCOMPA (perampanel) 10 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania. FYCOMPA is an oral anticonvulsant medication used as adjunctive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 MG tablets (30-count supply) valued at $1,752.54 under a firm fixed price contract type. The delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,965.36 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on May 30, 2025, with a completion date of June 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $4,169.69 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 6 mg tablets (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $1,837.44. This firm fixed-price delivery order, which is expected to be completed by February 14, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Fycompa (perampanel) is an oral anticonvulsant medication used...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for FYCOMPA 4 mg tablets (30-count package) with a ceiling value of $2,067.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 24, 2025, and the place of performance is located in Conshohocken, PA. This delivery...
- The Defense Logistics Agency awarded a $12,464.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340 ml) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The performance location...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXYDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,332.68 to AmerisourceBergen Drug Corp for FYCOMPA (perampanel) 10 mg tablets in a quantity of 30 on September 22, 2025, with completion expected by September 23, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA is a neurological medication used as an adjunctive treatment for seizures, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceuticals to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contracting history demonstrates its capability to fulfill diverse medical procurement requirements through competitive awards, positioning it as a critical supplier within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/22/25 |